| scholarly article | Q13442814 |
| P2093 | author name string | Daniel H Conrad | |
| Sheinei J Saleem | |||
| P2860 | cites work | Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood | Q47742734 |
| Notch1 expression in early lymphopoiesis influences B versus T lineage determination | Q51085324 | ||
| Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. | Q51093180 | ||
| Direct evidence for the commitment of hematopoietic stem cells to T, B and myeloid lineages in murine fetal liver | Q51102224 | ||
| Hematopoietic and lymphopoietic responses in human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor transgenic mice injected with human GM-CSF | Q52193365 | ||
| Human granulocyte-macrophage colony-stimulating factor (hGM-CSF) induces inhibition of intrathymic T-cell development in hGM-CSF receptor transgenic mice. | Q52196162 | ||
| IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage | Q52546757 | ||
| C/EBPbeta is required for 'emergency' granulopoiesis | Q53619729 | ||
| Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor | Q54421148 | ||
| Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses | Q59280526 | ||
| Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor | Q70971859 | ||
| Notch1 perturbation of hemopoiesis involves non-cell- autonomous modifications | Q77584403 | ||
| Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo | Q77620517 | ||
| c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors | Q78225131 | ||
| Activation of vascular endothelial growth factor receptor-2 in bone marrow leads to accumulation of myeloid cells: role of granulocyte-macrophage colony-stimulating factor | Q81099226 | ||
| Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations | Q24298328 | ||
| Blood monocytes: development, heterogeneity, and relationship with dendritic cells | Q24314793 | ||
| Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells | Q24316878 | ||
| Notch1 and Notch2 Inhibit Myeloid Differentiation in Response to Different Cytokines | Q24533662 | ||
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| The Jak-Stat pathway in normal and perturbed hematopoiesis | Q28141000 | ||
| ICSBP/IRF-8: its regulatory roles in the development of myeloid cells | Q28201638 | ||
| G-CSF and its receptor in myeloid malignancy | Q28276273 | ||
| Type I interferon: friend or foe? | Q28293186 | ||
| IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways | Q28297876 | ||
| Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate | Q28298291 | ||
| Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2 | Q28298733 | ||
| IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP | Q28575310 | ||
| Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha | Q28589867 | ||
| Stroma-mediated granulocyte-macrophage colony-stimulating factor (GM-CSF) control of myelopoiesis: spatial organisation of intercellular interactions. | Q44492119 | ||
| ADAM10 Overexpression Shifts Lympho- and Myelopoiesis by Dysregulating Site 2/Site 3 Cleavage Products of Notch | Q44963738 | ||
| Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease | Q45018029 | ||
| Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines | Q45046201 | ||
| Myeloproliferative disease in mice with reduced presenilin gene dosage: effect of gamma-secretase blockage | Q28591999 | ||
| The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
| Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
| Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. | Q32061796 | ||
| Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells | Q33181844 | ||
| Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. | Q33326050 | ||
| IRF8 regulates myeloid and B lymphoid lineage diversification | Q33579478 | ||
| Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation | Q33588887 | ||
| Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells | Q33707270 | ||
| ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo | Q33730084 | ||
| Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. | Q33780538 | ||
| Stepwise reprogramming of B cells into macrophages | Q33978638 | ||
| IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells | Q34095907 | ||
| The growing diversity and spectrum of action of myeloid‐derived suppressor cells | Q34151972 | ||
| STAT3 controls myeloid progenitor growth during emergency granulopoiesis | Q34193520 | ||
| Regulation of Granulocyte and Macrophage Populations of Murine Bone Marrow Cells by G-CSF and CD137 Protein | Q34403700 | ||
| Stem and Progenitor Cells: Origins, Phenotypes, Lineage Commitments, and Transdifferentiations | Q34425181 | ||
| Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13 | Q34541778 | ||
| A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma | Q34699543 | ||
| Hematopoietic cytokines | Q34734185 | ||
| Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. | Q35000965 | ||
| Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells | Q35052425 | ||
| The role of VEGF in normal and neoplastic hematopoiesis | Q35052515 | ||
| Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells | Q35207759 | ||
| Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression | Q35478848 | ||
| Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow | Q35634878 | ||
| The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity | Q35750663 | ||
| Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. | Q35900957 | ||
| Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice | Q35955690 | ||
| The aging innate immune system | Q36220810 | ||
| MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis | Q36229458 | ||
| Notch signalling via RBP-J promotes myeloid differentiation. | Q36246257 | ||
| Colony-stimulating factor-1 in immunity and inflammation. | Q36335789 | ||
| Vascular endothelial growth factor in the lung | Q36364992 | ||
| Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion | Q36370397 | ||
| Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer | Q36597391 | ||
| Hematopoietic stem cells: expression profiling and beyond | Q36672249 | ||
| Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation | Q36684653 | ||
| Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages | Q36713525 | ||
| Metabolic mechanisms of cancer-induced inhibition of immune responses. | Q36891305 | ||
| Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy | Q36944371 | ||
| IRF8 regulates B-cell lineage specification, commitment, and differentiation | Q36969752 | ||
| The transcriptional regulation of the Colony-Stimulating Factor 1 Receptor (csf1r) gene during hematopoiesis | Q36991859 | ||
| Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity | Q36996588 | ||
| Notch signaling in differentiation and function of dendritic cells | Q37002843 | ||
| Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells | Q37147482 | ||
| Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. | Q37382352 | ||
| Untangling the T branch of the hematopoiesis tree | Q37408715 | ||
| A new paradigm for hematopoietic cell lineages: revision of the classical concept of the myeloid-lymphoid dichotomy | Q37438995 | ||
| A revised scheme for developmental pathways of hematopoietic cells: the myeloid-based model | Q37669569 | ||
| Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice | Q37696753 | ||
| Myeloid derived suppressor cells and their role in tolerance induction in cancer | Q37767006 | ||
| The multifaceted effects of granulocyte colony‐stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis | Q37777393 | ||
| Myeloid-derived suppressor cells in transplantation. | Q37794627 | ||
| Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function | Q37808561 | ||
| Transcription factors in myeloid-derived suppressor cell recruitment and function. | Q37827980 | ||
| A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression | Q38294949 | ||
| STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation | Q38303450 | ||
| CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression. | Q38345794 | ||
| Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics | Q40011425 | ||
| Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
| A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations | Q40249893 | ||
| High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells | Q40519826 | ||
| Notch signaling induces multilineage myeloid differentiation and up-regulates PU.1 expression. | Q40646120 | ||
| The common myelolymphoid progenitor: a key intermediate stage in hemopoiesis generating T and B cells | Q40702395 | ||
| Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome | Q40744630 | ||
| Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis | Q40884139 | ||
| Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics | Q40977649 | ||
| Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17 | Q41023409 | ||
| Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. | Q41050761 | ||
| Interaction between PU.1 and another Ets family transcription factor promotes macrophage-specific Basal transcription initiation. | Q41050906 | ||
| Myelopoiesis and myeloproliferative disorders | Q41157143 | ||
| Requirement for nuclear factor (NF)-kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. | Q41472401 | ||
| Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines | Q41615530 | ||
| Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions | Q41667805 | ||
| Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals | Q42086334 | ||
| IL6 to the rescue | Q42249027 | ||
| VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism | Q44043571 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 808-815 | |
| P577 | publication date | 2011-03-21 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | International Immunopharmacology | Q15751306 |
| P1476 | title | Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion | |
| P478 | volume | 11 |
| Q40501904 | Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection. |
| Q55287562 | Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata. |
| Q49456387 | Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease |
| Q33750877 | Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells. |
| Q38578686 | Myeloid-derived suppressor cells in B cell malignancies. |
| Q55311061 | Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses. |
| Q28079046 | Phenotype, development, and biological function of myeloid-derived suppressor cells |
| Q34811936 | Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice |
| Q37965750 | Role of myeloid-derived suppressor cells in tumor immunotherapy |
| Q89587286 | Shaping of the Tumor Microenvironment by Notch Signaling |
| Q37553132 | Stat3 and C/EBPβ synergize to induce miR-21 and miR-181b expression during sepsis |
| Q38239562 | The roles of myeloid-derived suppressor cells in transplantation |
| Q38113760 | microRNAs as potential regulators of myeloid-derived suppressor cell expansion |
| Q48164135 | γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma. |
Search more.